Literature DB >> 17297015

Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects.

W Weber1, B Kis, R Siekmann, D Kuehne.   

Abstract

BACKGROUND AND
PURPOSE: We report our experiences in the treatment of intracranial arteriovenous malformations (AVMs) with Onyx embolization before neuro- or radiosurgery, focusing on the embolization technique with Onyx.
METHODS: Ninety-three patients (40 women and 53 men, mean age 38 years) with 94 intracranial AVMs with a mean volume of 9.2 mL were embolized with Onyx. The following features of all AVMs were evaluated before the treatment: type of nidus and shunt, draining veins, and feeding arteries.
RESULTS: Complete obliteration rates were 20% at the end of all embolization steps and 53% after embolization and surgery. In 21% of patients the final control angiography is not yet available (after surgery 9%, after radiosurgery 12%). In 4% of patients, radiosurgery was planned due to a persistent arteriovenous shunt. The injection of Onyx resulted in high occlusion rates (volume reduction >90%) when the AVM was in a supratentorial and cortical location, the nidus was compact and plexiform, and when there was a small number of supplying (direct) feeders and one superficial draining vein. Access device-related complications (stuck catheter, vessel perforation) occurred during the embolization of 220 feeding arteries in 6% of patients, with all such instances having had no clinical consequences.
CONCLUSION: With knowledge of the morphologic characteristics of AVMs that are suitable for a treatment with Onyx, high occlusion rates and low complication rates in treating a small number of feeders are feasible. Superselective intranidal or perinidal catheter positions and slow, controlled injections that protect the draining veins make the therapy safe even in complex AVMs and critical locations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17297015      PMCID: PMC7977391     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  AHA Scientific Statement: Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association.

Authors:  C S Ogilvy; P E Stieg; I Awad; R D Brown; D Kondziolka; R Rosenwasser; W L Young; G Hademenos
Journal:  Stroke       Date:  2001-06       Impact factor: 7.914

2.  The relevance of anatomic and hemodynamic factors to a classification of cerebral arteriovenous malformations.

Authors:  A Pasqualin; G Barone; F Cioffi; L Rosta; R Scienza; R Da Pian
Journal:  Neurosurgery       Date:  1991-03       Impact factor: 4.654

3.  Endovascular treatment of B-AVM.

Authors:  K G Terbrugge
Journal:  Interv Neuroradiol       Date:  2004-10-22       Impact factor: 1.610

4.  Ethanol endovascular management of brain arteriovenous malformations: initial results.

Authors:  W F Yakes; L Krauth; J Ecklund; R Swengle; J N Dreisbach; C E Seibert; R Baker; M Miller; G VanderArk; T Fullagar; E Prenger
Journal:  Neurosurgery       Date:  1997-06       Impact factor: 4.654

5.  A reexamination of the angiotoxicity of superselective injection of DMSO in the swine rete embolization model.

Authors:  J C Chaloupka; D C Huddle; J Alderman; S Fink; R Hammond; H V Vinters
Journal:  AJNR Am J Neuroradiol       Date:  1999-03       Impact factor: 3.825

6.  Effect of partial targeted N-butyl-cyano-acrylate embolization in brain AVM.

Authors:  H J Meisel; U Mansmann; H Alvarez; G Rodesch; M Brock; P Lasjaunias
Journal:  Acta Neurochir (Wien)       Date:  2002-09       Impact factor: 2.216

7.  Embolization of cerebral arteriovenous malformations achieved with polyvinyl alcohol particles: angiographic reappearance and complications.

Authors:  T Sorimachi; T Koike; S Takeuchi; T Minakawa; H Abe; K Nishimaki; Y Ito; R Tanaka
Journal:  AJNR Am J Neuroradiol       Date:  1999-08       Impact factor: 3.825

8.  Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience.

Authors:  Francesco Florio; Walter Lauriola; Michele Nardella; Vincenzo Strizzi; Stefano Vallone; Marco Pastore Trossello
Journal:  Radiol Med       Date:  2003 Nov-Dec       Impact factor: 3.469

9.  [Endovascular embolization of cerebral arteriovenous malformation].

Authors:  Tielin Li; Chuanzhi Duan; Qiujing Wang; Fangming Yin; Gang Zhao; Zhian Han; Qing Huang; Ruxiang Xu
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-05-25

10.  Nonadhesive liquid embolic agent for cerebral arteriovenous malformations: preliminary histopathological studies in swine rete mirabile.

Authors:  Y Murayama; F Viñuela; A Ulhoa; Y Akiba; G R Duckwiler; Y P Gobin; H V Vinters; R J Greff
Journal:  Neurosurgery       Date:  1998-11       Impact factor: 4.654

View more
  74 in total

1.  Balloon-assisted technique for trapped microcatheter retrieval following onyx embolization. A case report.

Authors:  A Santillan; W Zink; J Knopman; H Riina; Y P Gobin
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

2.  Onyx distal embolization in transarterial embolization of dural arteriovenous fistula with subtotally isolated transverse-sigmoid sinus. A case report.

Authors:  Y Jiang; Y Li; Z Wu
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

3.  Speech Reorganization after an AVM Bleed Cured by Embolization. A Case Report and Review of the Literature.

Authors:  R La Piana; D Klein; Mdp Cortes; D Tampieri
Journal:  Interv Neuroradiol       Date:  2009-12-28       Impact factor: 1.610

4.  Radiosurgical treatment planning of AVM following embolization with Onyx: possible dosage error in treatment planning can be averted.

Authors:  Natan Shtraus; Dan Schifter; Benjamin W Corn; Shimon Maimon; Shlomi Alani; Vladimir Frolov; Diana Matceyevsky; Andrew A Kanner
Journal:  J Neurooncol       Date:  2010-04-10       Impact factor: 4.130

5.  Treatment of brain arteriovenous malformations by double arterial catheterization with simultaneous injection of Onyx: retrospective series of 17 patients.

Authors:  D G Abud; R Riva; G S Nakiri; F Padovani; M Khawaldeh; C Mounayer
Journal:  AJNR Am J Neuroradiol       Date:  2010-10-21       Impact factor: 3.825

6.  Risk factors of intracranial hemorrhage after brain AVM interventional therapy and its effects on prognosis.

Authors:  Guobin Li; Kun Han; Haiying Yang; Hui Huang; Hong Yang; Dezhang Zhu
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  Microcatheter entrapment retrieval from Onyx embolization in brain arteriovenous malformations: A technical note.

Authors:  Phat D Vu; Arthur A Grigorian
Journal:  Interv Neuroradiol       Date:  2015-07-31       Impact factor: 1.610

8.  The use of Onyx for embolization of peripheral vascular malformations in pediatric patients.

Authors:  Murat Cantasdemir; Fatih Gulsen; Serdar Solak; Gokce Yalcin Gulsen; Fatih Kantarci; Furuzan Numan
Journal:  Pediatr Surg Int       Date:  2012-01-22       Impact factor: 1.827

9.  Transarterial coil-augmented Onyx embolization for brain arteriovenous malformation. Technique and experience in 22 consecutive patients.

Authors:  Xu Gao; Guobiao Liang; Zhiqing Li; Xiaogang Wang; Chunyong Yu; Peng Cao; Jun Chen; Jingyuan Li
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

10.  Feasibility and outcomes of endovascular embolization of cerebral arteriovenous malformations at a low-volume centre.

Authors:  K Sobh; A Hegazy
Journal:  J Vasc Interv Neurol       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.